INVO Fertility, Inc (NASDAQ:IVF) Short Interest Update

INVO Fertility, Inc (NASDAQ:IVF) saw a large growth in short interest in the month of February. As of February 27th, there was short interest totaling 533,091 shares, a growth of 87.3% from the February 12th total of 284,595 shares. Currently, 7.7% of the shares of the stock are short sold. Based on an average daily volume of 1,337,849 shares, the days-to-cover ratio is currently 0.4 days. Based on an average daily volume of 1,337,849 shares, the days-to-cover ratio is currently 0.4 days. Currently, 7.7% of the shares of the stock are short sold.

Hedge Funds Weigh In On INVO Fertility

A hedge fund recently bought a new stake in INVO Fertility stock. Armistice Capital LLC purchased a new stake in shares of INVO Fertility, Inc (NASDAQ:IVF) during the 4th quarter, according to its most recent filing with the SEC. The institutional investor purchased 207,644 shares of the company’s stock, valued at approximately $156,000. Armistice Capital LLC owned about 8.69% of INVO Fertility at the end of the most recent quarter. 12.02% of the stock is currently owned by institutional investors and hedge funds.

Wall Street Analyst Weigh In

A number of research firms recently commented on IVF. Maxim Group set a $4.00 price target on INVO Fertility in a report on Tuesday, February 10th. Wall Street Zen upgraded shares of INVO Fertility from a “sell” rating to a “hold” rating in a research report on Saturday, March 7th. One analyst has rated the stock with a Strong Buy rating and one has assigned a Sell rating to the company’s stock. According to data from MarketBeat, the company currently has a consensus rating of “Moderate Buy” and a consensus target price of $4.00.

INVO Fertility Trading Up 5.4%

Shares of NASDAQ:IVF opened at $0.86 on Friday. The company has a market cap of $5.99 million, a price-to-earnings ratio of 0.00 and a beta of 2.66. INVO Fertility has a 12 month low of $0.71 and a 12 month high of $80.64. The company has a 50-day moving average price of $1.08 and a 200 day moving average price of $3.29.

About INVO Fertility

INVO Fertility (NASDAQ:IVF) is a medical technology company focused on advancing assisted reproductive treatments through innovative in-vivo incubation solutions. The company develops and commercializes devices designed to facilitate fertilization and early embryo development inside a patient’s body, offering an alternative to conventional laboratory-based in vitro fertilization (IVF) techniques.

The company’s flagship product, the INVOcell device, is a single-use, intravaginal incubator that holds a controlled microenvironment for egg and sperm co-incubation.